Telaprevir, Boceprevir, Cytochrome P450 and Immunosuppressive Agents - A Potentially Lethal Cocktail

被引：62

作者：

Charlton, Michael ^{[1
]}

机构：

[1] Mayo Clin, Dept Gastroenterol & Hepatol, Transplant Ctr CH 10, Rochester, MN 55905 USA

来源：

HEPATOLOGY | 2011年 / 54卷 / 01期

关键词：

RECURRENT HEPATITIS-C; LIVER-TRANSPLANTATION; ANTIVIRAL THERAPY; GRAFT-SURVIVAL; HCV INFECTION; VIRUS; INTERFERON; CYCLOSPORINE; TACROLIMUS; RECIPIENTS;

D O I：

10.1002/hep.24470

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：3 / 5

页数：3

共 18 条

[1] Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C [J].

Abdelmalek, MF ;

Firpi, RJ ;

Soldevila-Pico, C ;

Reed, AI ;

Hemming, AW ;

Liu, C ;

Crawford, JM ;

Davis, GL ;

Nelson, DR .

LIVER TRANSPLANTATION, 2004, 10 (02) :199-207

[2] Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation [J].

Berenguer, M. ;

Palau, A. ;

Aguilera, V. ;

Rayon, J. -M. ;

Juan, F. S. ;

Prieto, M. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) :679-687

[3] PHOENIX: A Randomized Controlled Trial of Peginterferon Alfa-2a Plus Ribavirin as a Prophylactic Treatment After Liver Transplantation for Hepatitis C Virus [J].

Bzowej, Natalie ;

Nelson, David R. ;

Terrault, Norah A. ;

Everson, Gregory T. ;

Teng, Lichen L. ;

Prabhakar, Avinash ;

Charlton, Michael R. .

LIVER TRANSPLANTATION, 2011, 17 (05) :528-538

[4] Long-term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK Liver Transplantation Database [J].

Charlton, M ;

Ruppert, K ;

Belle, SH ;

Bass, N ;

Schafer, D ;

Wiesner, RH ;

Detre, K ;

Wei, YL ;

Everhart, J .

LIVER TRANSPLANTATION, 2004, 10 (09) :1120-1130

[5] Interleukin-28B Polymorphisms Are Associated With Histological Recurrence and Treatment Response Following Liver Transplantation in Patients With Hepatitis C Virus Infection [J].

Charlton, Michael R. ;

Thompson, Alexander ;

Veldt, Bart J. ;

Watt, Kym ;

Tillmann, Hans ;

Poterucha, John J. ;

Heimbach, Julie K. ;

Goldstein, David ;

McHutchison, John .

HEPATOLOGY, 2011, 53 (01) :317-324

[6] A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation [J].

Crippin, JS ;

McCashland, T ;

Terrault, N ;

Sheiner, P ;

Charlton, MR .

LIVER TRANSPLANTATION, 2002, 8 (04) :350-355

[7] Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy [J].

Everson, GT ;

Trotter, J ;

Forman, L ;

Kugelmas, M ;

Halprin, A ;

Fey, B ;

Ray, C .

HEPATOLOGY, 2005, 42 (02) :255-262

[8] No improvement in long-term liver transplant graft survival in the last decade: An analysis of the UNOS data [J].

Futagawa, Y ;

Terasaki, PI ;

Waki, K ;

Cai, J ;

Gjertson, DW .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (06) :1398-1406

[9] Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus [J].

Garg, Varun ;

van Heeswijk, Rolf ;

Lee, Jee Eun ;

Alves, Katia ;

Nadkarni, Priya ;

Luo, Xia .

HEPATOLOGY, 2011, 54 (01) :20-27

[10] Pharmacokinetic interaction between amprenavir/ritonavir and FosAmprenavir on cyclosporine in two patients with human immunodeficiency virus infection undergoing orthotopic liver transplantation [J].

Guaraldi, G ;

Cocchi, S ;

Codeluppi, M ;

Di Benedetto, F ;

Bonora, S ;

Motta, A ;

Luzi, K ;

Pecorari, M ;

Gennari, W ;

Masetti, M ;

Gerunda, GE ;

Esposito, R .

TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) :1138-1140

← 1 2 →